PMDA drug package insert
アラジル ニキビ治療薬
PMDA OTC drug · 明治薬品（株） · package insert Dec 12, 2024
Key facts
| Brand names | アラジル ニキビ治療薬 |
|---|---|
| Companies | 製造販売元／万協製薬（株）,販売会社／明治薬品（株） |
| Product type | OTC drug |
| OTC risk class | 第２類医薬品 |
| OTC dosage form | 塗布剤 |
| OTC effect category | 化膿性疾患用薬 |
| Package insert date | Dec 12, 2024 |
| PMDA document key | 630357_J2401000165 |
| PMDA company code | 630357 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: